Quali sono gli orari di apertura?

Lunedì 09:00 - 18:00 Martedì 09:00 - 18:00 Mercoledì 09:00 - 18:00 Giovedì 09:00 - 18:00 Venerdì 09:00 - 18:00

Angiodroid

Angiodroid Srl is an Italian innovative Company that projects and trade solutions for the medical market. Angiodroid® The CO2 Injector is our main product.

Angiodroid SpA is a medical technology company specialized in vascular surgery, interventional radiology and interventional cardiology, dedicated to developing a new generation of automatic injectors for angiography using carbon dioxide as contrast agent. It is a Carbon Dioxide (CO2) Injector for Interventional Radiology procedures and represents the perfect solution for the treatment of patients

with:

• Diabetic Disease
• Renal Failure
• Intolerance to Iodinated contrast media

The use of CO2 in Peripheral Angiography has been common practice for many decades. To date, however, it has not the proper success due to the lack of advanced technology which could support operators during the procedures. Until now, the market solution was the use of manual injection kits (that means no procedural repeatability, no control of injection pressure and air contamination risk). Angiodroid® The CO2 Injector, whose main fields of application are Interventional Radiology & Vascular Surgery, is the perfect solution to all these problems and is the only injector:

• 100 % automatic
• 100 % safe
• 100 % digital
• 100 % user friendly

More info at www.angiodroid.com

22/04/2026

Can be done without iodine? The short answer is: yes!

As the shows, EVAR is no longer a concept.

In fact, this multicentre study that involved some of our biggest has brought some impressive numbers:

🫧293 patients - 10 centres
🫧82% procedures with CO₂ only
🫧99.7% technical success
🫧>10x lower AKI vs iodine
🫧Minimal iodine use (only 18%)

But that's not all! Can you guess what other value was greatly impacted? Well, keep following us, some great news about safety is just around the corner ☢️...

CO₂ angiography is no longer limited to niche cases; with the right protocol and technology, it enables a standardized, safe, and kidney-friendly EVAR workflow.

At Angiodroid, we believe this is the direction vascular imaging is heading:

👉 Reducing contrast-related risks
👉 Improving patient safety
👉 Enabling more sustainable procedures
The future of EVAR is evolving, and it’s increasingly contrast-free

We'd like to thank Emiliano Chisci, Emanuele Ferrero, Michele Antonello, Luca Mezzetto, Raffaele Pulli, Giacomo Isernia, Mauro Gargiulo, Giovanni Pratesi, Luca Bertoglio, Stefano Michelagnoli and the Zero Iodine Contrast EVAR Collaborative Study Group for making this possible.

04/04/2026

🐰 Every , we're faced with a pretty tough choice: dark chocolate or milk chocolate?

🍫 Usually there are factions for both sides, but apart from personal taste, can you call yourself a "chocolate connoisseur"?

🥚 Well, we've collected a few facts for the upcoming chocolate bunnies and eggs you'll be unwrapping! And maybe, just maybe, you'll cross over to the other side...

For now, happy Easter from the family to yours!

02/04/2026

🛡️ Preserving should remain a priority, even during vascular access procedures.

For we take a look at the study "Carbon dioxide automated digital subtraction angiography for endovascular arteriovenous fistulas creation" led by Prof. Dr. Matteo Tozzi, which explores how CO₂ angiography enables creation without nephrotoxic contrast, opening new possibilities for patients.

❓ Could CO₂ become the new standard in selected cases?

Read the full text here: https://journals.sagepub.com/doi/10.1177/11297298221126814?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed

31/03/2026

Why "Preservation" is in our DNA 🏥🛡️

At , we believe that innovation in healthcare shouldn't just be about treating a condition—it should be about preserving the patient's future.

Traditional iodinated contrast media ( ) has long been the gold standard, but it comes with a silent risk: Contrast-Induced Nephropathy ( ). For patients with existing renal impairment, diabetes, or those requiring repeated procedures, the "cost" of a clear image shouldn’t be their kidney function.

Read more about the data here: https://www.angiodroid.com/angiodroid-is-preservation

27/03/2026

incontra Bimbo Tu per una stupenda giornata di team building piena di divertimento e scoperte! 🤜🤛

🧒👧 è l’associazione che supporta i bambini ricoverati in Neurochirurgia pediatrica e le loro famiglie, finanziando progetti ospedalieri, contribuendo a migliorare gli spazi di cura e offrendo un aiuto concreto durante il percorso di degenza presso gli Ospedale Bellaria, Policlinico di Sant'Orsola e Ospedale Maggiore; nella loro sede, ci siamo impegnati nella (difficile!) costruzione di puzzle 3D per i bambini ospiti della struttura, accompagnati da filastrocche e canzoni per ogni opera.

❤️ Ringraziamo tutti i volontari di Bimbo Tu per l'organizzazione della giornata e per averci aperto le porte del loro mondo, pieno di sorrisi e affetto.

Scoprite di più sull'associazione e su come potete aiutare anche voi: https://bimbotu.it/

26/03/2026

🏥 At the Parly II Private Hospital in Chesnay-Rocquencourt, interventional radiology teams are leading the way in patient safety by utilizing as a contrast agent for arterial examinations.

In France, one in ten people is affected by . During procedures like and , traditional iodine contrast requires a significant metabolic effort from the kidneys to be eliminated. For patients with already weakened organs, this additional stress can lead to kidney failure.

🚀 On the other hand, CO₂ brings many advantages to the table, for patient safety, organ preservation, synergistic efficiency and proven impact.

Since its introduction at Parly II in 2018, more than a thousand patients have benefited from this safer alternative.

Listen to the interview with one of our , Dr. Massimiliano Di Primio right here: https://tv78.com/hopital-parly2-co2-imagerie-vasculaire/

19/03/2026

🍌🥝🍈🥑 For we'd like to convey a message that is just as simple as it is overlooked: fruit is delicious and surely healthy, but sometimes the it contains might pose a threat in case of declining function.

This means that some fruits that are perfectly healthy for the general population may require portion control for people with chronic kidney disease ( ), and here's a breakdown of what happens as the condition worsens.

When kidneys filter less, even fruit becomes a calculation.

Read more on our website: https://www.angiodroid.com/savethekidneys-fruit-and-potassium

18/03/2026

🛡️ Approximately 850 million people worldwide are estimated to have , most of whom live in low-income and lower-middle-income countries (LICs and LMICs), and a large proportion of these individuals lack access to kidney disease , or .

📈 In contrast to disease, and disease, mortality has been rising, and by 2040, it's projected to be the 5th highest cause of years of life lost (YLL) globally.

As one of our leading , Prof. Matteo Tozzi, puts it, that is why resorting now to is more important than ever; every little action taken helps preserve and save a life.

Begin your CO2 Journey here: https://www.angiodroid.com/contacts

17/03/2026

✍️ On March 5-6, beautiful was the stage of another amazing Workshop, hosted by Dr. Emiliano Chisci (Director of Endovascular Aortic Surgery Unit), Dr. Stefano Michelagnoli (Director of Vascular Surgery Unit) and Simone Panci (Interventional Radiographer), in collaboration with Philips.

Two intensive days of theoretical training and cases, where participants were able to discuss and witness the application of in , , , visceral and renal , treatment and much more, with the support of radiographers Daniela Incerti, Giuseppe Martone, Lisa Verna, Lorenzo Ciampi.

Using a Philips Azurion angiography system, they could experience first-hand the feasibility of procedures with CO2:

💧 it's safe and effective in almost all clinical scenarios;
💧 it can be used together with ICM and often by itself, thanks to its imaging quality;
💧 reducing ICM usage is essential, both for patient safety and for the environment.
Moreover, the last procedure of the workshop was completed with a DAP of just 20.5 Gy/cm², highlighting how optimized protocols and technology can significantly reduce exposure.

Once again, we thank all participants and the San Giovanni di Dio Vascular Team for the outstanding results, and we hope to see you at the next !

Become a expert:
https://share-eu1.hsforms.com/1UdfUvCPaRZOY1NUxg12Kagf39q1

13/03/2026

For , our very own Global Clinical Director and - Business Development Manager Luca Monti tells us about his experience in , from the challenging beginnings in his area to the (spoiler: many!) proud moments along the way, in his never-ending quest to raise awareness about , in order to preserve .

If you'd like to find out more about and its clinical applications and you're based in , , or , then he's the person for you; or you can contact us, we'll be happy to help! https://www.angiodroid.com/contacts

11/03/2026

Could be the game-changer for kidney protection in vascular surgery? 🫀

Patients with Peripheral Arterial Disease ( ) and Chronic Kidney Disease ( ) face a high risk of Acute Kidney Injury ( ) during endovascular revascularization, largely due to the nephrotoxic nature of traditional iodinated contrast media.

The KID Trial is stepping up to address this clinical challenge 🛡️

What is the KID Trial?

This multicentre, prospective randomized controlled trial is investigating whether using an automated CO2 injector reduces the risk of AKI compared to the standard iodinated approach, and Angiodroid is glad to be helping with this important study

Post-procedural AKI is associated with higher mortality, cardiovascular events, and long-term renal decline. By generating robust, definitive evidence on the utility of automated , this study could lead to a significant shift in clinical practice and improved outcomes for our most vulnerable patients.

Kudos to Chief Investigator Prof. Athanasios (Thanos) Saratzis and the entire research team for leading this pivotal work!

10/03/2026

🛡️ As part of the Ministry of Health and Population’s commitment to introducing the latest technologies in specialized and advanced surgical procedures, Nasser Institute Hospital in has successfully performed an endovascular abdominal aortic aneurysm repair ( ) using only CO₂ as a contrast medium, marking the first time this procedure has been carried out at the hospital.

📍 Now, a dedicated injector is permanently available at the hospital, enabling this type of advanced intervention in accordance with the latest international standards.

We thank Dr. Moemen Mesalam, Dr. Abd elaziz Mersal and their team for performing this procedure and highlighting how can preserve , as well as our Clinical Specialist Wessam Nabil and our partner AMS for on-site clinical support.

💡Find out the many pros of Zero-Contrast techniques: https://www.angiodroid.com/contacts

Indirizzo

Via Speranza 35
San Lazzaro Di Savena
40068

Orario di apertura

Lunedì	09:00 - 18:00
Martedì	09:00 - 18:00
Mercoledì	09:00 - 18:00
Giovedì	09:00 - 18:00
Venerdì	09:00 - 18:00

Telefono

+39051463269

Sito Web

http://www.angiodroid.com/

Notifiche

Lasciando la tua email puoi essere il primo a sapere quando Angiodroid pubblica notizie e promozioni. Il tuo indirizzo email non verrà utilizzato per nessun altro scopo e potrai annullare l'iscrizione in qualsiasi momento.